Chronic Spontaneous Urticaria Learning Zone
Transcript: Delays in providing treatment for CSU
Marcus Maurer, MD, and Petra Staubach-Renz, MD
All transcripts are created from interview footage and directly reflect the content of the interview at the time. The content is that of the speakers and is not adjusted by Medthority.
- Petra, we gotta move on. We have so many interesting topics here that we wanted to cover, but we got stuck on comorbidities, a very important topic. But I remember beating the burden of chronic urticaria, or when doctor becomes patient. I'm not sure which episode it was. You have to look it up. These are really episodes that deal with our treatment goals and also with why we fail sometimes. You know, why is it that still so many patients are out there undertreated, with uncontrolled urticaria? What can we do to reduce the diagnostic delay and especially reduce the getting held up with treatment. Why do we not get patients on effective treatment faster than we do? What do you think is the main reason for patients not getting what they really need? - Yeah, I think we are typical German. Maybe the others can answer your question. Because shouldn't we be happy that we have such a good management? No, we are not happy, of course, but we have done a good job the last years. Of course, it could be better, but maybe we have to do small steps.
And I think this new forms of communities, going to the patient groups, we have some new groups from patients who are talking to patients and so on. And I think we are doing different things in different ways and that's the solution, to go to the patients. It's not worse to go to those who do not want to treat the patients and so on, but go to those they want to treat, - Yeah. - or to join the community. - In compliance to guidelines, is Jong Hun Li, answer to the question that you just answered.
Why does it take so long? Or why do we never bring patients to effective treatment? I do agree with you. Yes, if more people were to read and follow the guideline, yes, then we would have better treatment out there for patients with chronic urticaria. So let's spread the word, the guideline is out. Do translate them. Do use them in your country. Make them known to non-urticaria experts. Make them known to patients and empower patients so that they can benefit from these new guidelines. - And in my experience, it always takes some years to go through the whole world. And if they know how easy it is to be successful or to treat successfully the patient, then they will follow. No question. No doubt. - Absolutely. Absolutely.
This content has been developed independently by Medthority who previously received educational funding from Novartis in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.